Pinned Tweet
Happy to report the first clinical evidence revealing how tumors develop resistance to p53-Y220C reactivators out today @CD_AACR @MassGenBrigham @harvardmed #CorcoranLab #Rezatapopt #p53Y220C #PYNNACLE
aacrjournals.org/cancerdiscover…
2
5
14
3,741
Ferran Fece de la Cruz retweeted
Fa 15 anys vaig arribar a Barcelona per perseguir un somni: convertir l'impossible en una nova oportunitat per als pacients amb càncer.

Gràcies a @diariARA i @saez_cristina per explicar la nostra història i celebrar la força de la recerca catalana! ❤️

ara.cat/ciencia-medi-a…
0
6
27
746
Ferran Fece de la Cruz retweeted
You can have a fun lab without sleeping with the fellows in the program you direct!
One of the things that got me about the @DMSabatini story was the allegation that his lab promoted “bro culture.” Not only is being a bro not a crime (no matter what some might have you think) but labs, especially ones that operate at such a high level, rely on people being ed, and yes, having fun. I loved Sabatini’s response to my question in my interview with him for @PirateWires, on how American science has become corporate and sterile:
28
21
467
31,905
A record 7,710 proposals – a 60.4% increase to 2026 – for #ERCStG 2027! Physical Sciences & Engineering are in the lead (43%), followed by Social Sciences & Humanities (29%), and Life Sciences (28%).
erc.europa.eu/news-events/ne…
0
0
0
129
Ferran Fece de la Cruz retweeted
Anyone interested in cancer medicine needs to see the current front page of @NEJM
nejm.org
It's one historic advance after another after another on there right now
22
177
836
55,964
Ferran Fece de la Cruz retweeted
When shareholders are informed before the medical community… this is not respectful to investigators and patients involved in clinical trials.
#ESMO26: The embargo on LBA1, “INTerpath-001: Phase 3 study of the mRNA-based individualised neoantigen therapy intismeran autogene plus pembrolizumab versus pembrolizumab alone for adjuvant treatment of resected stage IIB-IV melanoma”, has been breached. As the data are now publicly available, ESMO has released the information contained in the abstract and has lifted the embargo on the full dataset.
0
2
6
671
Topoisomerase inhibitor vs. a B7-H3-targeting ADC linked to a topoisomerase inhibitor payload 🤯
Good news for the #SCLC community! @SclcSMASHERS @NEJM #Phase3
nejm.org/doi/full/10.10…
0
1
1
130
“Women living with #mBC face an uphill battle as their tumors evolve to escape treatment. This marks the first FDA approval guided by the detection of a resistance mutation in ctDNA before imaging tests show that the disease is progressing." #SERENA6 #ESR1
fda.gov/news-events/pr…
0
0
1
130
Ferran Fece de la Cruz retweeted
Reconeixement a l'excel·lència de la recerca

📢 5 investigadors del sistema català de coneixement reben ajuts Starting Grant de l’@ERC_Research

Són els més prestigiosos i competitius del món i impulsen l'inici de la carrera científica

Mésℹ️
🔗 erc.europa.eu/news-events/ne…
#ERCStG
0
22
57
3,293
Ferran Fece de la Cruz retweeted
Estic molt il·lusionat d’anunciar que la “Ribas Family Early Career Professorship in Catalan and Romance Languages and Cultures” de la Universitat de Michigan ha obert el període de presentació de candidatures per a una plaça de professor titular. Aquesta càtedra permanent és una família a la Universitat i al Govern i poble de Catalunya, en part per agraïment per les beques que em van concedir durant els meus estudis de doctorat en enginyeria.

I’m excited to announce that the “Ribas Family Early Career Professorship in Catalan and Romance Languages and Cultures” at the University of Michigan is now inviting applications for a tenure-track position. This Professorship is my family’s endowment and contribution to both the University and the Government and people of Catalonia who supported me financially through my PhD studies in Engineering.

Please find more details on the position here: msft.it/6015appbt
54
549
1,459
81,312
Ferran Fece de la Cruz retweeted
Congrats!! Love to see when first authors in @CD_AACR move on to start their own labs!
@ElizSMcKenna 🙋🏻‍♂️
0
3
30
5,387
Ferran Fece de la Cruz retweeted
🌍🔬 Catalunya és terra de recerca, innovació i oportunitats

Amb el programa impulsat per #IDIBAPS, @ISGLOBALorg i @HMar_research, promovem la llengua i la cultura catalanes per afavorir la integració del talent internacional

Benvinguts a Catalunya!👋
0
3
9
768
Ferran Fece de la Cruz retweeted
The US FDA have now approved this drug for use against a cancer previously thought to be "undruggable"

go.nature.com/4qHLuOr
5
95
384
59,169
Melanoma to rhabdomyosarcoma transformation after ICB and HDAC-i. Let's talk about tumor evolution under treatment pressure 🤯 @MedCellPress
cell.com/med/abstract/S…
0
0
2
204
Ferran Fece de la Cruz retweeted
A new study reveals mechanisms of resistance to daraxonrasib, highlighting putative combination approaches. Read the News & Views from Grainne O'Kane & colleagues: dlvr.it/TV46sH
0
15
54
12,526
Ferran Fece de la Cruz retweeted
Please join us at the inaugural MGB Cancer Institute Pancreatic Cancer Symposium @MGBResearchNews, details linked tinyurl.com/2xba57j3
2
2
22
1,818